Jens‐Oliver Koopmann

Author

German Cancer Research Center

Also Known As

J Koopmann, J. Koopmann, J.-O. Koopmann, Jens KOOPMANN, Jens-Oliver Koopmann, Jens‐Oliver Koopmann

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

German Cancer Research Center Heidelberg University AstraZeneca (United Kingdom)University of Bonn AstraZeneca (Netherlands)

About

Jens‐Oliver Koopmann is an author at German Cancer Research Center specializing in medicine, cell biology, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.1K
2	Natural Sciences	2	2	168
3	Engineering	1	1	28
4	Health Sciences	1	1	407
5	Biochemistry	1	1	153

Jens‐Oliver Koopmann

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson, Cancer Immunology Research ImmunologyImmunoeditingImmunotherapeutic Drug DiscoveryImmunotherapeuticsImmunotherapy	2016	407
A Viral ER-Resident Glycoprotein Inactivates the MHC-Encoded Peptide Transporter Hartmut Hengel, Jens‐Oliver Koopmann, Thomas Flohr, Immunity ImmunologyAntiviral ResponseVirologyViral Er-resident GlycoproteinProtein Transport	1997	316
Export of Antigenic Peptides from the Endoplasmic Reticulum Intersects with Retrograde Protein Translocation through the Sec61p Channel Jens‐Oliver Koopmann, Jörn C. Albring, Eva N. Huter, Immunity Protein SecretionSignal TransductionBiochemistryNatural SciencesMedicine	2000	153
Translocation of long peptides by transporters associated with antigen processing (TAP) Jens‐Oliver Koopmann, Markus Post, Jacques Neefjes, European Journal of Immunology	1996	151
The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment Edmund Poon, Stefanie Mullins, Amanda Watkins, Journal for ImmunoTherapy of Cancer	2017	73
Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients Lianhua Bai, Jens‐Oliver Koopmann, Christoph Fiola, International Journal of Oncology ImmunologyImmunoeditingImmunotherapeuticsCancer PatientsImmune Cell Therapy	2002	66
Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours Jens‐Oliver Koopmann, David Maintz, Steven E. Schild, British Journal of Cancer Neuro-oncologySomatic VariantWaf1/cip1 GeneMedicineGenetics	1995	60
The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics Monique Grommé, R. van der Valk, Karen Sliedregt, European Journal of Immunology	1997	49
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR Shenlan Mao, Raghothama Chaerkady, Wen Yu, Molecular Cancer Therapeutics	2021	31
High affinity capture surface for matrix‐assisted laser desorption/ionisation compatible protein microarrays Jens‐Oliver Koopmann, Jonathan M. Blackburn Rapid Communications in Mass Spectrometry Maldi TargetEthylene GlycolEngineeringMolecular BiologyProtein Purification	2003	28

Page 1